BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6480016)

  • 1. Pharmacokinetics of dextropropoxyphene and nordextropropoxyphene in elderly hospital patients after single and multiple doses of distalgesic. Preliminary analysis of results.
    Crome P; Gain R; Ghurye R; Flanagan RJ
    Hum Toxicol; 1984 Aug; 3 Suppl():41S-48S. PubMed ID: 6480016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicological studies in a Distalgesic addict.
    Roberts I; Flanagan RJ; Strang J; Prescott LF
    Hum Toxicol; 1986 May; 5(3):207-10. PubMed ID: 3710498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of dextropropoxyphene and nordextropropoxyphene in young and elderly volunteers after single and multiple dextropropoxyphene dosage.
    Flanagan RJ; Johnston A; White AS; Crome P
    Br J Clin Pharmacol; 1989 Oct; 28(4):463-9. PubMed ID: 2590604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP3A4 mediates dextropropoxyphene N-demethylation to nordextropropoxyphene: human in vitro and in vivo studies and lack of CYP2D6 involvement.
    Somogyi AA; Menelaou A; Fullston SV
    Xenobiotica; 2004 Oct; 34(10):875-87. PubMed ID: 15764408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of therapeutic doses of meptazinol and a dextropropoxyphene/paracetamol mixture alone and in combination with ethanol on ventilatory function and saccadic eye movements.
    Ali NA; Marshall RW; Allen EM; Graham DF; Richens A
    Br J Clin Pharmacol; 1985 Dec; 20(6):631-7. PubMed ID: 4091995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextropropoxyphene kinetics after single and repeated oral doses in man.
    Brøsen K; Gram LF; Schou J; Larsen NE; Thayssen P
    Eur J Clin Pharmacol; 1985; 29(1):79-84. PubMed ID: 4054208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of dextropropoxyphene and nordextropropoxyphene in biological fluids.
    Flanagan RJ; Ramsey JD; Jane I
    Hum Toxicol; 1984 Aug; 3 Suppl():103S-114S. PubMed ID: 6480009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracetamol + dextropropoxyphene: planned withdrawal from the British market.
    Prescrire Int; 2005 Aug; 14(78):145. PubMed ID: 16108102
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of dextropropoxyphene + acetaminophen fixed-dose combination in psychiatric hospital in Bahrain: is there a cause for concern?
    Al Khaja KA; Al-Haddad MK; Al-Offi AR; Abdulraheem MH; Sequeira RP
    Fundam Clin Pharmacol; 2009 Apr; 23(2):253-8. PubMed ID: 19645819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption and elimination of D-propoxyphene, acetyl salicylic acid, and phenazone in a combination tablet (Doleron): comparison between young and elderly subjects.
    Melander A; Bodin NO; Danielson K; Gustafsson B; Haglund G; Westerlund D
    Acta Med Scand; 1978; 203(1-2):121-4. PubMed ID: 626106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextropropoxyphene deaths: coroner's report.
    Whittington RM
    Hum Toxicol; 1984 Aug; 3 Suppl():175S-185S. PubMed ID: 6480014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene.
    Inturrisi CE; Colburn WA; Verebey K; Dayton HE; Woody GE; O'Brien CP
    Clin Pharmacol Ther; 1982 Feb; 31(2):157-67. PubMed ID: 7056023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of analgesics in intentional drug overdose presentations to hospital before and after the withdrawal of distalgesic from the Irish market.
    Corcoran P; Reulbach U; Keeley HS; Perry IJ; Hawton K; Arensman E
    BMC Clin Pharmacol; 2010 Mar; 10():6. PubMed ID: 20298551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gas chromatographic method for the determination of dextropropoxyphene and nordextropropoxyphene in human plasma, serum and urine.
    Angelo HR; Christensen JM
    J Chromatogr; 1977 Oct; 140(3):280-93. PubMed ID: 914919
    [No Abstract]   [Full Text] [Related]  

  • 15. [Proctitis following the prolonged use of dextropropoxyphene and paracetamol suppositories: the risk persists despite change of excipient].
    Marteau P; Flourié B; Froguel E; Contou JF; Galian A; Rambaud JC
    Gastroenterol Clin Biol; 1990; 14(1):102-3. PubMed ID: 2311842
    [No Abstract]   [Full Text] [Related]  

  • 16. Deaths from paracetamol and dextropropoxyphene (Distalgesic) poisoning in England and Wales in 1979.
    Vale JA; Buckley BM; Meredith TJ
    Hum Toxicol; 1984 Aug; 3 Suppl():135S-143S. PubMed ID: 6480012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic method for the determination of dextropropoxyphene and nordextropropoxyphene in serum.
    Angelo HR; Kranz T; Strøm J; Thisted B; Sørensen MB
    J Chromatogr; 1985 Dec; 345(2):413-8. PubMed ID: 4086610
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioavailability of aspirin in the presence of dextropropoxyphene/paracetamol combination.
    Hemming JD; Bird HA; Pickup ME; Saunders A; Lowe JR; Dixon JS
    Pharmatherapeutica; 1981; 2(8):543-6. PubMed ID: 7255511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):219-25. PubMed ID: 2987139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anorectal stenosis caused by suppositories of dextropropoxyphene and paracetamol (Diantalvic)].
    Hemet J; Leroy A; Duprey F; Rocher W; Metayer J; Ducastelle T
    Gastroenterol Clin Biol; 1986; 10(6-7):517-20. PubMed ID: 3758596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.